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ABSTRACT
hDIS3 is a mainly nuclear, catalytic subunit of the
human exosome complex, containing exonucleoly-
tic (RNB) and endonucleolytic (PIN) active domains.
Mutations in hDIS3 have been found in 10% of
patients with multiple myeloma (MM). Here, we
show that these mutations interfere with hDIS3
exonucleolytic activity. Yeast harboring correspond-
ing mutations in DIS3 show growth inhibition and
changes in nuclear RNA metabolism typical for
exosome dysfunction. Construction of a conditional
DIS3 knockout in the chicken DT40 cell line revealed
that DIS3 is essential for cell survival, indicating
that its function cannot be replaced by other
exosome-associated nucleases: hDIS3L and
hRRP6. Moreover, HEK293-derived cells, in which
depletion of endogenous wild-type hDIS3 was com-
plemented with exogenously expressed MM hDIS3
mutants, proliferate at a slower rate and exhibit
aberrant RNA metabolism. Importantly, MM muta-
tions are synthetically lethal with the hDIS3 PIN
domain catalytic mutation both in yeast and
human cells. Since mutations in PIN domain alone
have little effect on cell physiology, our results
predict the hDIS3 PIN domain as a potential drug
target for MM patients with hDIS3 mutations. It is
an interesting example of intramolecular synthetic
lethality with putative therapeutic potential in
humans.
INTRODUCTION
Multiple myeloma (MM) is a lethal neoplastic disease ac-
counting for 10–15% of hematologic malignances and
20% of deaths related to cancer of the blood and bone
marrow (1). MM originates from terminally differentiated
antibody-producing B cells known as plasma cells (1).
The genetic background of MM is not completely
understood. Hypermutations occurring at the time of
immunoglobulin receptor affinity maturation and class
switching are involved in MM pathogenesis, leading to
chromosomal abnormalities such as translocations,
hyperdiploidy, hypodiploidy, monosomy or partial
deletion of chromosome 13 (1–3). A recent whole-
genome sequencing of 38 MM patients provided a
global view on the somatic mutations associated with
this cancer (4). Unexpectedly, hDIS3 gene was mutated
in 10% of MM patients (4). Importantly, these muta-
tions were either homo- or hemizygotic. A high frequency
of hDIS3 gene mutations in MM patients was recently
confirmed in another high-throughput study (5).
Interestingly, hDIS3 gene mutations were also found in
global screens of other cancers, such as medulloblastoma
and acute myeloid leukemia (6,7). Additionally, hDIS3
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was identified in transcriptomic analyses as one of the
genes, whose expression differentiates superficial spread-
ing melanoma from nodular melanoma (8). Furthermore,
hDIS3 overexpression was earlier observed in human colo-
rectal cancer and in a mouse model of this cancer, where
elevated levels of respective mRNA and protein positively
correlated with the incidence of metastasis (9,10).
Expression profiling revealed that hDIS3 is among
several genes whose loss-of-function significantly reduces
viability of colorectal carcinoma cell lines (11). Increased
levels of hDIS3 mRNA have been also recently proposed
as one of the characteristics of the epithelial ovarian
cancer (12). All examples presented above strongly
suggest the existence of possible molecular link between
hDIS3 functions and development of different cancers [re-
viewed in (13)]. More specifically, it appears likely that
exonucleolytic activity of hDIS3 protein—the major cata-
lytic subunit of the exosome—might be somehow involved
in this association.
hDIS3 is a catalytic subunit of the RNA exosome,
which plays a crucial role in RNA processing and decay.
The exosome complex has an evolutionarily conserved
structure encompassing a 9-subunit ring devoid of any
catalytic activity (14,15). The associated ribonucleases re-
sponsible for the enzymatic activity of the exosome belong
to two different families: Dis3 proteins, similar to bacterial
RNases II/R, and Rrp6 proteins, members of the RNase
D family (16). In yeast, single genes code for Dis3 and
Rrp6 proteins. Dis3 is the only essential catalytic
subunit, present both in the nucleus and cytoplasm,
while Rrp6 is restricted to the nucleus and responsible
for only a subset of nuclear exosome functions (17).
Dis3 is a multidomain protein with two different catalytic
activities: a 30–50 exonucleolytic activity via the RNase
II/R (RNB) domain and an endonucleolytic activity via
the PilT N-terminal (PIN) domain at the N-terminus
(16,18–20). The Dis3 exonuclease active site is located
near the bottom of the central channel of the 9-subunit
ring through which substrates are delivered (21–25). Both
activities cooperate with each other, but the exonucleolytic
activity is more important for cell physiology, whereas
mutations abolishing the endonucleolytic activity alone
have no detectable growth phenotype (18–20,24).
The human genome encodes three Dis3 homologues, of
which only hDIS3 and hDIS3L were found to associate
with the exosome (26,27). Notably, both of them are
processive 30–50 hydrolytic exonucleases, whereas only
hDIS3 has also retained endonuclease activity in its
PIN domain. In vivo localization studies and analyses of
substrate specificities revealed that hDIS3L is restricted
to the cytoplasmic exosome, whereas hDIS3 is mainly a
nucleoplasmic protein, with a small fraction present in
the cytoplasm (26,27). Additionally, human RRP6 is
mainly nuclear and significantly enriched in the nucleoli,
with a minor fraction in the cytoplasm (26). Thus, human
RNA exosomes, although based on the same structural
scaffold as their Saccharomyces cerevisiae counterparts,
exist as functionally and compositionally distinct variants
in different areas of the nucleus and in the cytoplasm (28).
The third human Dis3 homologue—hDIS3L2—does
not interact with the exosome core, due to the lack of
PIN domain and it has been recently demonstrated by
several independent studies that it is responsible for an
alternative 30–50 RNA decay pathway in the cytoplasm
(29–31). An important role of hDIS3L2 in the mainten-
ance of proper cellular metabolism is supported by the fact
that mutations in its gene were found to be associated with
Perlman syndrome of overgrowth and predisposition to
Wilm’s tumor development (13,32).
The exosome plays a fundamental role in most RNA
metabolic pathways (16,33,34). These pathways include
turnover of normal mRNAs and AU-rich element-
regulated decay of unstable mRNAs (35,36); nuclear pro-
cessing of stable RNA classes (small nuclear RNA
(snRNA), small nucleolar RNA (snoRNA), rRNA,
tRNA) (17,37); degradation of unstable transcripts
arising from intergenic regions (38–40); and complete deg-
radation of mRNA after endonucleolytic cleavage
initiated by small interfering RNA (siRNA) in RNA inter-
ference (41). Furthermore, the exosome plays a crucial
role in the quality control, as it is a primary enzyme
degrading unwanted molecules in the nucleus and the
cytoplasm, including incorrectly processed pre-mRNAs,
rRNAs and tRNAs as well as translationally incompetent
mRNAs (17,37,42–47). Apart from its well-documented
role in RNA metabolism, a recent study has implicated
the exosome in the activation-induced immunoglobulin
heavy-chain class switch recombination and immuno-
globulin variable region somatic hypermutation in
human B lymphocytes (48). It was also suggested that
the exosome is essential for activation-induced cytidine
deaminase (AID) recruitment to chromatin (48), but the
mechanistic details of this process remain elusive.
Here, we explored the consequences of hDIS3 gene mu-
tations found in MM patients using biochemical, genetic
and functional analyses, and examined possible synthetic
genetic interactions between hDIS3 exonucleolytic activity
and other catalytic activities of the nuclear exosome.
MATERIALS AND METHODS
Cell culture and generation of stable cell lines
Human HEK293 Flp-In T-REx (Invitrogen) cells were
cultured as monolayers in Dulbecco’s modified Eagle’s
medium (D-MEM, Gibco) supplemented with 10% tetra-
cycline-free fetal bovine serum (TET System Approved
Fetal Bovine Serum (FBS); Clontech) and antibiotics
(penicillin-streptomycin; Sigma-Aldrich) at 37C in a 5%
CO2 humidified atmosphere.
The stable inducible HEK293 Flp-In T-REx cell lines
were obtained in this study using highly pure DNA
midipreps of pMM7-pMM14 plasmid constructs (Supple-
mentary Table S3; see Supplementary Materials and
Methods for details on construction of the plasmids)
and the Flp-InTM T-RExTM system (Invitrogen), accord-
ing to the protocol of the manufacturer. Established cell
lines were grown in the same medium as above, supple-
mented with hygromycin B (100mg/ml) and blasticidin
(10–15 mg/ml) (both from Invitrogen). Transfections were
performed with Lipofectamine2000 (Invitrogen).
Expression of exogenous genes was induced by addition
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of doxycycline to the culture medium at a final concentra-
tion of 100 ng/ml.
The chicken DT40 Cre1 cell line was obtained from
the laboratory of Jean-Marie Buerstedde (Institute for
Molecular Radiobiology, Neuherberg-Munich, Germany).
DT40 cells were cultured in D-MEM supplemented with
10% FBS (Invitrogen), 1% chicken serum (Sigma-
Aldrich), 0.1mM 2-mercaptoethanol (Sigma-Aldrich), 100
U/ml of penicillin and 0.1mg/ml of streptomycin (Sigma-
Aldrich) at 37C in a 5% CO2 humidified atmosphere. Cell
densities were kept between 0.2 and 2 million per 1ml.
Stable integration of pMM15 and pMM16 constructs
(Supplementary Table S3; see Supplementary Materials
and Methods for details on construction of the
plasmids) into the DT40 DIS3 locus with the aim of
generating conditional knockouts was performed as
follows. DT40 Cre1 cells (107) were centrifuged, resus-
pended in 0.8ml of growth medium and incubated on
ice for 10 min with 40 mg of the respective plasmid
linearized with NotI restriction enzyme. The cells were
then electroporated in ice-chilled 0.4 cm cuvettes
(Biorad) using the following parameters: 700V, 25 mF.
The cells were transferred into 10ml of medium and
cultured for 24 h in small flasks. Ten milliliters of
medium with the proper selection antibiotic was added
(puromycin or blasticidin S, both from Invivogen; final
concentrations of 0.5mg/ml and 20 mg/ml, respectively),
and cells were transferred to 96-well plates (200 ml each
well). After 7–14 days, single colonies were counted
under the microscope and resuspended in 1.5ml of fresh
medium containing selection antibiotics. Surviving cells
were collected for further analysis. The stable
heterozygotic puromycin-resistant DT40 Cre1 cell line
(dis3DPuroR/DIS3) was generated following one round of
transfection with the pMM15 construct. To obtain the
stable homozygotic puromycin- and blastidicin S-resistant
DT40 Cre1 cell line (dis3DPuroR/dis3DBsrR), a second round
of electroporation was performed using the pMM16
construct.
The conditional DIS3 knockout in DT40 Cre1-derived
cell lines obtained above was achieved through Cre-
mediated LoxP excision of the hDIS3 expression cassette
induced by 4-hydroxy-tamoxifen. Briefly, cells (106) were
cultured for 48 h in presence of 10 mM 4-hydroxy-tamoxi-
fen (Sigma-Aldrich). Cells were counted and subcloned in
a set of dilutions to obtain single colonies on 96-well
plates. After 5–7 days, colonies were counted under the
microscope, and cells were resuspended and split into two
media: with or without selection antibiotic(s). Colonies
that did not survive exposure to antibiotic(s) were
treated as cultures with complete LoxP excision.
Cell growth analyses
Stable inducible human HEK293 Flp-In T-REx cell lines
were grown as described above in 100mm plates until
reaching 90% confluence. In the 48-h induction mode,
2 105 cells were plated directly in six-well plates in
medium either lacking or containing doxycycline, and
grown for another 48 h. In the 48-h+48-h induction
mode, the cells were first replated in new 100mm plates
in medium either lacking or containing doxycycline at
40% confluence. After 48 h, 2 105 cells were plated in
six-well plates in the respective medium and grown for
another 48 h. Cell growth and eGFP fluorescence were
analyzed using an Olympus IX81 microscope.
Metabolic activity assays of the cell lines were per-
formed as follows. Cells (5 103) were plated in triplicate
(for each cell line, condition and time of measurement) in
96-well plates. Cells were either maintained in medium
lacking doxycycline or subjected to treatment with the
inducer. At various time points following induction (24,
72 or 120 h), 10 ml of AlamarBlue (Invitrogen) was added
to the cultures. Amounts of the reduced reagent were
quantified after 120 min using the DTX880 Multimode
Detector (Beckman Coulter).
Western blotting
Protein samples from yeast cultures and human or chicken
cell lines were prepared according to standard protocols,
run on 10–12% sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels and immobilized on
Protran nitrocellulose membranes (Whatman) by
electrotransfer using Trans-Blot SD Semi-Dry Transfer
Cell (Bio-Rad). Following transfer, membranes were
stained with Ponceau S Red (Sigma-Aldrich; 0.1% in 3%
acetic acid), blocked in 5% nonfat milk in Tris-buffered
saline (TBS) containing 0.05% Tween-20 (TBST), and
incubated in the same solution with primary antibodies.
The following primary antibodies were used for analyses:
mouse monoclonal anti-eGFP (B2) (Santa Cruz
Biotechnology; sc-9996) (1:1000), rabbit polyclonal anti-
FLAG (Sigma-Aldrich; F-7425) (1:3000), rabbit polyclonal
anti-hDIS3 (Sigma-Aldrich; HPA039281, lot: R37348)
(1:1500), rabbit polyclonal anti-hDIS3L (Sigma-Aldrich;
HPA041805, lot: R38591) (1:500), rabbit polyclonal anti-
hRRP6 (Sigma-Aldrich; P4124) (1:3000), rabbit polyclonal
anti-hDIS3L2 (31) (1:2000) and goat polyclonal anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(V-18) (Santa Cruz Biotechnology; sc-20357) (1:2000).
Membranes were then washed with TBST and incubated
with appropriate secondary antibody [goat anti-mouse,
goat anti-rabbit (Calbiochem; 401215, 401393, respectively)
or rabbit anti-goat (Sigma-Aldrich; A5420)] conjugated with
horseradish peroxidase. Protein A tag was detected directly
using rabbit Peroxidase–Anti-Peroxidase Soluble Complex
antibody (Sigma-Aldrich; P1291) (1:3000). Blots were de-
veloped in a Curix 60 machine (AGFA) using the Immun-
StarTM WesternCTM Kit (Bio-Rad) and CL-XPosureTM
Films (Thermo Scientific).
Heterologous expression and purification of hDIS3
proteins
For purification of the panel of hDIS3 variants, the
Escherichia coli BL21-CodonPlus-RIL strain (Stratagene)
was first transformed with appropriate plasmids (pHEX1,
pHEX8 or pMM1-pMM6). Transformants were grown at
18C for 48h in 1 l of Auto Induction Media Super Broth
Base Including Trace Elements (Formedium) supplemented
with 2% glycerol, kanamycin (30mg/ml) and chlorampheni-
col (34mg/ml), following inoculation from a pre-culture,
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grown in standard Luria-Broth (LB) medium containing
both antibiotics. Recombinant proteins were purified as
described previously (26,49), with minor modifications.
Exoribonuclease assays
In vitro enzymatic assays of hDIS3 exoribonucleolytic
activity were performed in 20ml reaction volumes containing
10mM Tris–HCl, pH=8.0, 75mM NaCl, 1mM
2-mercaptoethanol and 100mM MgCl2. Protein concentra-
tion was 0.1mM, while substrate concentration was 0.2 or
2mM for duplex or unstructured RNA molecules, respect-
ively. Details on the preparation of radiolabeled substrates
can be found in the Supplementary Materials and Methods.
For gel-based analyses, reactions were performed at
37C for the indicated times and terminated by adding
20 ml of formamide loading dye (90% formamide,
20mM EDTA, 0.03% bromophenol blue, 0.03% xylene
cyanol in 1Tris-borate-EDTA (TBE)). Reaction
products were resolved in denaturing 20% polyacryl-
amide, 8M urea, 1 TBE gels. In the case of thin layer
chromatography (TLC)-based experiments, samples were
collected by mixing aliquots of the reaction mixtures with
1 ml of 0.5M EDTA, and subsequently analyzed by
running them on polyethylenimine (PEI)-cellulose plates
(Schleicher & Schuell) in 0.5M LiCl/1M formic acid using
nonradioactive uridine monophosphate (UMP) as a
marker. For both types of analyses, reaction products
were visualized using a FUJI PhosphorImager.
Southern hybridization
Approximately 10 mg of genomic DNA isolated from
DT40-derived cell lines was digested overnight with 40
U of either NdeI or BsaI restriction enzyme (both from
ThermoScientific) in a total volume of 100 ml, according to
the manufacturer’s instructions. Digested DNA was
precipitated according to standard laboratory procedures
and loaded onto a 0.6% agarose gel stained with ethidium
bromide. Electrophoresis was performed in 1Tris-
acetate-EDTA (TAE) buffer at 8C. Following DNA sep-
aration, gel was sequentially submerged for 30 min with
gentle agitation in (i) depurination solution (0.25M HCl),
(ii) denaturation solution (1.5M NaCl, 0.5M NaOH) and
(iii) neutralization buffer (1.5M NaCl, 0.5M Tris–HCl,
pH 7.5). The gel was briefly rinsed with H2O between
different steps of incubation described above. Finally,
DNA was transferred overnight onto a Hybond N+
membrane (GE Healthcare), according to the manufac-
turer’s instructions, and fixed by ultraviolet cross-linking.
The polymerase chain reaction (PCR) product spanning
a 480-bp fragment of the chicken DIS3 right arm was
amplified from the pMM15 construct with the
DIS3_RF-DIS3rfinR primer pair (see Supplementary
Table S2 for sequences). The amplification product was
gel-purified and used as a probe for hybridization.
Approximately 25 ng of PCR product was labeled with
a-32P[dATP] using the DECAprimeTM II Kit (Ambion)
according to the manufacturer’s instructions. After de-
naturation and snap-cooling, labeled probe was purified
using Micro Bio-Spin Column P-30 Tris (Biorad).
Hybridization was performed at 68C overnight in
PerfectHyb Plus hybridization buffer (Sigma-Aldrich).
The membrane was washed twice with 2saline-sodium
citrate (SSC), 0.1% SDS and once in 0.5SSC, 0.1%
SDS at 68C for 20 min, and eventually exposed to a
PhosphorImager screen (FujiFilm), which was scanned
following exposure using a FLA 7000 scanner (FujiFilm).
RNA isolation and northern-blot analysis
RNA was isolated from yeast cultures and human cell
lines using the standard hot acidic phenol procedure or
TRI Reagent (Sigma-Aldrich), respectively. Total RNA
(5–10mg) was fractionated by electrophoresis either in
denaturing 6% polyacrylamide-urea gel followed by
electroblotting onto a Hybond N+ membrane in 0.5
TBE at 4C, or in a 1% formaldehyde-agarose gel,
followed by RNA immobilization on the same type of
membrane by overnight capillary transfer in 20 SSC
(3M NaCl, 0.3M sodium citrate). RNA was fixed on
membranes by ultraviolet cross-linking. Hybridizations
were performed in PerfectHyb Plus hybridization buffer.
The blots were handled according to standard procedures
and probed at 42C (50-labeled oligonucleotide probes) or
63C (DNA fragments labeled by random priming).
Between successive hybridizations, probes were stripped
off the membranes at 65C using boiling 0.1% SDS.
For detection of yeast 50-external transcribed spacer
(ETS) and NEL025 cryptic unstable transcript (CUT),
PCR probes labeled by random priming with
a-32P[dATP] and DecaLabel DNA Labeling Kit
(Thermo Scientific) as described previously (18) were
used. Randomly primed PCR products, obtained with
the primer pairs GAPDH_F-GAPDH_R and 7SL_F-
7SL-R (Supplementary Table S2), were used as probes
for detection of GAPDH mRNA and 7SL RNA, respect-
ively. Randomly primed probe, generated as previously
described (26), was used for detection of the hDIS3 tran-
script. Randomly primed DNA probe specific to histone
H2A mRNA was generated by EcoRI/HindIII-mediated
excision of sequence corresponding to its full-length CDS
(GenBank ID: AY131971.1), cloned between respective
sites of pUC19; the construct was kindly provided by
Prof. Zbigniew Dominski. For all other transcripts, 32P-
labeled oligonucleotides (listed in Supplementary Table
S2) were used as probes. After hybridization, membranes
were washed with 2 SSC, 0.1% SDS and results were
visualized using phosphorimaging as described in the
previous section. Quantification was performed using
Multi Gauge v. 3.0 software (FujiFilm).
Reverse transcription and quantitative PCR
Total RNA (10 mg) extracted from stable human cell lines
was treated with 6 U of TURBOTM DNase (Ambion) in
the presence of RiboLockTM RNase Inhibitor (Thermo
Scientific), according to the manufacturer’s instructions.
Following phenol:chloroform extraction and precipitation
of RNA with isopropanol, 2 mg of DNase-treated RNA
was reverse transcribed using a mixture of 50 pmol of an
oligo(dT) primer and 250 ng of random hexamers
(Invitrogen) and Superscript IIITM reverse transcriptase
(Invitrogen), according to the manufacturer’s instructions,
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in a final volume of 20 ml. A portion (1/100) of the cDNA
reaction was mixed with Platinum Quantitative PCR
SuperMix-UDG (Invitrogen), 2.5 pmol of each primer
(Supplementary Table S2) and 0.3mg of bovine serum
albumin in a final volume of 10 ml and analyzed by real-
time PCR in a Roche LightCycler 480 system using an
annealing temperature of 58C. Negative controls lacking
reverse transcriptase showed a negligible background.
Analyses were performed in triplicate. All data were
normalized to GAPDH mRNA.
RESULTS
hDIS3 proteins with MM-associated mutations display
various defects in the degradation of different RNA
substrates in vitro
The majority of mutations found in MM affect conserved
residues in the hDIS3 RNB domain, suggesting their
impact on the exonucleolytic activity of the enzyme [(4);
Figure 1A]. In comparison, no cancer-associated muta-
tions have been found in the PIN domain, entirely respon-
sible for the endoribonucleolytic activity of hDIS3
(Figure 1A).
To analyze the impact of hDIS3 mutations identified in
MM patients by Chapman et al. (4) on the exonucleolytic
activity of the protein, recombinant versions of hDIS3
[wild-type (WT) or bearing different mutations detected
in MM] were purified from E. coli. We successfully
obtained hDIS3S477R, hDIS3V504G, hDIS3G766R,
hDIS3R780K and hDIS3I845V proteins (Figure 1B), but
were unable to purify hDIS3A524P, which was insoluble
irrespective of expression conditions. In parallel, we
purified two control hDIS3 variants: hDIS3WT, which
was previously shown to display robust exoribonucleolytic
activity, and hDIS3D487N, a catalytically inactive mutant
(exo) with one of the aspartic acid residues coordinating
magnesium in the active site of the RNB domain
substituted with its amide [(26); see Supplementary
Figure S6 therein, where hDIS3D487N is referred to as
hDIS3RNB MUT]. All recombinant proteins were
obtained with similar efficiency and comparable degree
of purity; the only significant contaminant was bacterial
DnaK chaperone, which was slightly increased for
hDIS3S477R, likely due to its lower solubility (Figure 1B).
Next, we performed a biochemical experiment using the
purified hDIS3 variants and in vitro transcribed RNA
(400-nt-long RNA fragment encompassing Arabidopsis
thaliana Lsm1 open reading frame) uniformly labeled with
UTP. Time-course–based analysis of RNA degradation by
TLC allowed us to tentatively assess the influence of indi-
vidual mutations on exoribonucleolytic activity. While the
degradative potential was almost unchanged in
hDIS3V504G and hDIS3I845V compared with hDIS3WT,
the activity was severely reduced for hDIS3S477R,
hDIS3G766R and hDIS3R780K (Figure 1C). The phenotype
of hDIS3R780K closely resembled that of the catalytic RNB
mutant in the active site (exo), hDIS3D487N (Figure 1C).
To more qualitatively assess defects in RNA degrad-
ation caused by hDIS3 mutations, we performed assays
on various 50-end labeled oligoribonucleotides: (i) a
single-stranded RNA, composed of 17-mer generic
sequence, followed by 14 nt-long oligo(A) tail [50P*-ss17-
(A)14]; (ii) a 44-mer, lacking oligo(A) extension (5
0P*-ss44)
and (iii) a structured substrate containing a 17-nt duplex
followed by a 14-nt-long oligo(A) tail [50P*-ds17-(A)14].
Decay products were analyzed on denaturing polyacryl-
amide gels (Figure 2). In the hDIS3I845V and hDIS3V504G
mutants, patterns of final degradation products were the
same as for hDIS3WT for all substrates (Figure 2A–C).
The rate of degradation was, however, slightly slower
for the hDIS3V504G variant compared with hDIS3WT
and hDIS3I845V. In contrast, the remaining mutations
had a visible impact on hDIS3 function. R780K led to
virtually complete inhibition of exonucleolytic degrad-
ation of both single-stranded substrates, similar to the
catalytic D487N mutation (Figure 2A and B), which con-
firmed the TLC results shown in the Figure 1B.
hDIS3S477R and hDIS3G766R variants displayed somewhat
milder defects on the 50P*-ss17-(A)14, in regard to changes
in the ratio of final degradation products compared with
hDIS3WT: for the former variant, the level of 4-nt-long
decay products was reduced, while with the latter, the
level was increased at the expense of decreased amounts
of 5-nt-long degradation products (Figure 2A). Moreover,
the hDIS3G766R mutant lost processivity and became dis-
tributive in the presence of 50P*-ss44 (Figure 2B).
Importantly, in the case of partially double-stranded
50P*-ds17-(A)14 substrate, while hDIS3
S477R, hDIS3G766R
and hDIS3R780K seemed to digest a single-stranded exten-
sion, they all stalled on encountering secondary structures
in the substrate (this effect was most pronounced with the
hDIS3R780K mutant), even though degradation of the par-
tial duplex was not completely abolished, as was the case
of hDIS3D487N catalytic mutant (Figure 2C).
Together, these results strongly indicate that the S477R,
G766R and R780K mutations in hDIS3 cause significant
aberrations of hDIS3 exoribonucleolytic activity, while
the V504G and I845V have subtle, if any, effects.
Mutations in yeast DIS3 gene corresponding to those
found in MM patients cause cell growth defects and
molecular phenotypes strongly suggesting impaired
exosome function
Since S. cerevisiae is the most widely used model for
studying Dis3 protein function, we started our functional
analyses of hDIS3 MM mutations by constructing yeast
strains expressing endogenous Dis3 with introduced
equivalent amino acid changes (with the exception
of hDIS3I845V, as this amino acid is not conserved in
yeast). We successfully produced four mutants: dis3-
G833R (corresponding to G766R in humans), dis3-
R847K (R780K), dis3-V568G (V504G) and dis3-A588P
(A524P), but not dis3-S541R (S477R).
We first performed growth tests with the yeast strains.
Both dis3-G833R and dis3-R847K displayed a strong
growth retardation phenotype compared with the WT
control, even at physiological temperature (Figure 3A).
The growth defect of dis3-G833R mutant was even
stronger than that observed for the dis3-D551N (D487N in
humans) catalytic mutant (exo). On the other hand, while
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the two other mutant strains, dis3-V568G and dis3-A588P,
grew normally at 30C, they appeared to be extremely
thermosensitive, as their growth was virtually completely
abolished at the elevated temperature (Figure 3A). The
observed phenotypes were not due to the lack of expression
of the DIS3 mutants, as confirmed by western blotting
against the protein A tag that was introduced at the 30-end
of all inserts during generation of the strains (Supplementary
Figure S1A; see Supplementary Materials and Methods for
details on strain construction). Moreover, successful
purification of the other exosome subunits using protein
A-tagged Dis3 variants as baits ruled out the possibility
that these phenotypes may result from protein instability
or inability to assemble into the complex (Supplementary
Figure S1B). Therefore, the results of growth tests of yeast
DIS3 mutants provided the first in vivo support that the
amino acids altered in MM patients might be important
for exosome function. Moreover, consistent with the
previous in vitro analyses, the V568 substitution exhibited
milder defects than G833 or R847 (Figure 3A).
Figure 1. Substitutions of conserved amino acids in the hDIS3 RNB domain decrease enzymatic activity. (A) Schematic view of domain organization
of human and yeast DIS3 proteins. Amino acids substituted in MM are indicated in light gray and their positions with respect to hDIS3 domains are
marked with arrows. An asterisk indicates position of D487, which was previously shown to be critical for exoribonucleolytic activity of hDIS3.
Corresponding amino acids in S. cerevisiae Dis3p are marked with italics. (B) SDS-PAGE analysis of hDIS3 protein variants purified using two-step
affinity chromatography, followed by gel filtration. Position of hDIS3 protein is marked with a solid arrow. Common contaminations with bacterial
DnaK chaperone and hDIS3 proteolytic degradation products are indicated with an asterisk and open arrows, respectively. The PageRulerTM
Prestained Protein Ladder (Fermentas) molecular marker is in the leftmost lane. (C) TLC analysis of the RNA degradation efficiency for recom-
binant hDIS3 proteins, shown in (B). Internally radiolabeled RNA, synthesized by in vitro transcription in the presence of [a-32P]UTP, was incubated
with equal amounts of hDIS3 variants or in the absence of protein. Aliquots were collected at indicated time points and spotted onto a PEI-cellulose
TLC plate, which was developed in the direction shown with the vertical gray arrow; positions of substrate and product (UMP) are indicated with
solid and open arrows, respectively. S477R, G766R and R780K mutations significantly inhibit ribonucleolytic degradation.
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Figure 2. hDIS3 mutations result in changes of the degradation pattern of unstructured RNA substrates and inability to degrade structured
substrates. (A) 50-labeled ss17-(A)14 substrate was incubated in a buffer containing 100 mM magnesium with equal amounts of hDIS3 variants or
in the absence of added protein. Reactions were terminated at the indicated time points, followed by denaturing PAGE and phosphorimaging.
Positions of substrate and 3–5 nt degradation products are marked with solid and open arrows, respectively. R780K mutation abolished the activity,
similar to D487N, while S477R and G766R substitutions led to a change in ratio of 5-nt/4-nt products. (B) Experiment was performed as in (A),
but using 50-labeled ss44 oligonucleotide. S477R and R780K mutations markedly reduced hDIS3 exoribonucleolytic activity. G766R
mutation resulted in the loss of processivity. (C) Experiment was performed as in (A), but using 50-labeled RNA substrate forming a partial
duplex ds17-(A)14. hDIS3
S477R, hDIS3G766R and hDIS3R780K proteins were not able to continue degradation of the substrate on encountering
double-stranded region.
1276 Nucleic Acids Research, 2014, Vol. 42, No. 2
(continued)
 at Instytut Biochem
ii i Biofizyki PA
N
 on M
ay 16, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Previous studies of Dis3exo mutant, which harbors a
mutation in the RNB domain that abolishes exonucleo-
lytic activity, showed that simultaneous inactivation of
either Rrp6 exonuclease or Dis3 PIN domain endonucle-
ase activity led to synthetic lethality (15,18–20). Therefore,
since G833R and R847K DIS3 mutations resulted in the
strongest growth phenotypes, we used these mutants to
check for any synthetic genetic interactions with RRP6
deletion or the D171N point mutation in Dis3 PIN
domain [previously shown to abolish endonucleolytic
activity of the protein, hereinafter referred to as
Dis3endo; see (18)]. Importantly both G833R and
R847K DIS3 mutations were synthetically lethal with
the Dis3endo mutation (Figure 3B), as in the case of
Dis3exo mutation. In contrast, only a slight synergistic
growth inhibition was observed on combination
of G833R and R847K DIS3 mutations with rrp6D
(Figure 3A).
We next tested the molecular effects of DIS3 gene mu-
tations in yeast by northern blot analyses on RNA
isolated from mutant and control strains using probes
for typical exosome substrates: the 50-ETS by-product of
ribosomal RNA processing, NEL025 CUT and 7S precur-
sor in the 5.8S rRNA maturation pathway. All DIS3 mu-
tations (the D551N substitution in the active site and four
mutations corresponding to those found in MM patients)
caused comparable accumulation of full-length 50-ETS
and 7S rRNA (without affecting the levels of mature 5.8
S rRNA in the latter case) compared with the WT strain
(Figure 3C). On the other hand, on examining levels of 7S
and 50-ETS degradation intermediates, as well as NEL025
CUT, we could divide DIS3 mutations into two classes:
one class that led to more significant accumulation of all
above-mentioned species (D551N, G766R and R780K),
and a second class with less pronounced effects (V568G
and A588) (Figure 3C). The results are consistent
with hDIS3 activity assays and yeast growth analysis
(Figures 2 and 3A). Combining DIS3 G766R or R780K
mutation with deletion of RRP6 did not seem to remark-
ably enhance the analyzed molecular phenotypes (except
perhaps additional accumulation of NEL025 CUT in
rrp6D dis3-G766R in comparison with dis3-G766R single
mutant) (Figure 3C).
Altogether, experimental results from the yeast model
suggest that changing amino acids in Dis3 positions analo-
gous to those mutated in MM patients affects S. cerevisiae
growth through the impairment of the exosome ability to
degrade its physiological substrates.
DIS3 is essential for survival of DT40 cell line
In contrast to yeast, the cellular role of vertebrate DIS3
and its potential redundancy with other exosome-
associated nucleases, RRP6 and DIS3L, has not been in-
tensively studied. Our previous siRNA-based experiments
in human cells did not reveal a strong effect of hDIS3
depletion on cell growth rate, and the molecular pheno-
types regarding potential substrates such as 5.8S rRNA
were relatively mild (26). Therefore, to assess the import-
ance of the DIS3 protein in the physiology of vertebrate
cells, we constructed a conditional DIS3 knockout using
DT40 chicken cells. The DT40 cell line has a high
rate of homologous recombination, which allows for
relatively straightforward generation of knockouts (50).
Conditionality is achieved by insertion of LoxP sites
into the integration cassettes and usage of a DT40 cell
line derivative expressing tamoxifen-inducible Cre recom-
binase (51). We constructed vectors for chicken DIS3
deletion that contained the human DIS3 cDNA
Figure 2. Continued
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Figure 3. Mutations in yeast DIS3 in positions analogous to those found in MM cause growth defects, molecular phenotypes and display synthetic
genetic interaction with catalytic mutation in the Dis3 PIN domain. (A) Serial dilutions of indicated yeast strains were spotted on YPD plates and
incubated at 25, 30 or 37C for 60 h. V568G and A524P mutations resulted in thermosensitivity, while G833R and R847K substitutions led to
growth inhibition at all tested temperatures. The two latter DIS3 point mutations seemed to give a slight synergistic effect in rrp6D background.
(B) Diploid heterozygotic strains DIS3 WT/dis3-D171N G833R-pA (top) and DIS3 WT/dis3-D171N R847K-pA (bottom), combining PIN domain
endo mutation with RNB mutations analogous to those found in MM were sporulated and subjected to tetrad dissection. Only two spores from
each tetrad were viable, demonstrating that MM-associated RNB domain mutations are synthetically lethal with D171N amino acid change,
abolishing endonucleolytic activity of Dis3 PIN domain. (C) Total RNA isolated from the strains in (A) was subjected to northern blot analysis
using probes specific to typical exosome substrates. DIS3 mutations (G833R and R847K in particular) caused accumulation of 50-ETS, NEL025
CUT and 7S precursor of 5.8S rRNA synthesis (as well as their degradation intermediates).
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expression cassette flanked by LoxP sites. Thus, after tam-
oxifen-regulated induction of Cre-recombinase, cells
would be devoid of DIS3 activity.
Two rounds of successful integrations into the DT40
genome resulted in construction of a cell line in which a
large part of the endogenous DIS3 gene was deleted
(Figure 4A) and hDIS3 was expressed, as verified by
Southern hybridization and western blotting, respectively
(Figure 4B and Supplementary Figure S1C). Modified
heterozygotic and homozygotic DIS3-knockout cells
were treated with 4-hydroxy-tamoxifen to excise the cas-
settes expressing hDIS3, and then subjected to subcloning.
Despite numerous attempts, it was not possible to obtain
clones with excised cassettes from the DIS3 homozygotic
knockout line, while these clones were successfully
obtained from the heterozygotic cell line. These results
suggest that the DIS3 gene is essential for survival of the
DT40 cell line.
MM-associated hDIS3 mutations result in accumulation
of different RNA species in the human cellular model
The promising results of the biochemical analyses and ex-
periments in yeast and DT40 cells prompted us to test the
impact of hDIS3 mutations in humans using a proper
cellular model. The most appropriate approach would
be to identify MM cell lines bearing different hDIS3
variants analyzed in previous experiments. However,
sequence analysis of several commercially available MM
cell lines did not reveal the presence of mutations in hDIS3
(Supplementary Figure S2A). Most surprisingly, we were
unable to confirm the sequence change detected by
Chapman et al (4) in H929 established cell lines from
two different sources (Supplementary Figure S2A and
B). Although the I845V mutation was identified in the
SKMM1 cell line (Supplementary Figure S2A and C),
we opted against using this line since the mutation does
not influence the exoribonucleolytic activity of the enzyme
(Figures 1C and 2). Therefore, we constructed our own
cellular model that would allow us to analyze the influence
of hDIS3 mutations on cell physiology and RNA metab-
olism. We combined the Flp-InTM T-RExTM system
from Invitrogen with a compatible vector containing a
bidirectional tetracycline-inducible promoter (52) (Sup-
plementary Figure S3; see Supplementary Materials and
Methods and Supplementary Figures S4 and S5 for details
on cloning strategy and construction of cell lines). This
experimental setup allowed us to generate HEK293 Flp-
In T-REx cell lines stably co-expressing (i) sh-microRNA
that silenced the endogenous hDIS3 copy and (ii) an ex-
ogenous hDIS3 variant tagged with a FLAG epitope and
containing a recoded fragment to render it insusceptible to
miRNA silencing (Supplementary Figure S3). We estab-
lished four cell lines exogenously expressing hDIS3WT, the
catalytic mutant hDIS3D487N or one of the two MM-
associated hDIS3 variants that had produced the strongest
phenotypes in previous experiments: hDIS3G766R and
hDIS3R780K. Northern and western blot analyses con-
firmed that both inserts were efficiently expressed in all
four cell lines (Supplementary Figure S6A and B).
Importantly, exogenous proteins were completely absent
from cells not subjected to induction, similarly to
nontransfected HEK293 Flp-In T-Rex cells, indicating
that the system that we used was relatively tight
(Supplementary Figure S6B). Before beginning experi-
ments, we first verified that the expression of other
known human 30–50 exonucleases involved in RNA metab-
olism, both cooperating with the exosome core, hDIS3L
and hRRP6, and functioning independently of the
complex (hDIS3L2), remained unchanged in our experi-
mental system (Supplementary Figure S6C). Furthermore,
immunolocalization experiments confirmed that neither
overexpression of hDIS3 nor the introduced mutations
influenced the intracellular localization of the protein
(Supplementary Figure S7A and B).
Using our model cell lines, we examined whether
expression of mutant hDIS3 proteins led to aberrations
in metabolism of RNA molecules representing various
classes. We isolated total RNA from the cells, which
were either untreated or subjected to doxycycline-
mediated induction for 48 h. Notably, after induction,
cells expressing hDIS3D487N and hDIS3R780K mutants
grew at a slightly lower rate than those producing
hDIS3WT or hDIS3G766R variants (data not shown).
First, we performed low-resolution northern blot
analysis for selected transcripts synthesized by different
RNA polymerases. Above all, we noticed significant accu-
mulation of unprocessed 5.8S ribosomal RNA precursors
(RNA polymerase I transcripts) following doxycycline-
mediated induction in cells bearing mutated hDIS3
variants (but not the WT counterpart) (Figure 5A). In
the case of RNA polymerase II transcripts, while
GAPDH polyA+ mRNA levels, used for normalization,
remained constant in all cell lines irrespective of induction,
we observed a clear increase of histone H2A polyA
mRNA amounts in cells expressing hDIS3D487N,
hDIS3G766R and hDIS3R780K mutant proteins
(Figure 5A; see Supplementary Figure S8A for quantifica-
tion). In regard to RNA polymerase III transcripts,
although expression of hDIS3 mutants did not seem
to have significant impact on RNase MRP RNA
(Figure 5A and Supplementary Figure S8A), the levels
of two other representative RNA species synthesized by
this enzyme, namely RNase P RNA and 7SL RNA, were
increased, particularly in cells producing hDIS3D487N and
hDIS3R780K variants (Figure 5A and Supplementary
Figure S8A). The phenotype observed for 7SL RNA was
also confirmed by high-resolution northern blot analysis
(Figure 5D).
As the degree of accumulation was the strongest for
5.8S rRNA precursors, we analyzed this in more detail
by high-resolution northern blots, using 5S rRNA as
loading control (Figure 5B). In general, we confirmed
that the levels of these species were elevated exclusively
on induction in cells with hDIS3 mutations (Figure 5B).
Additionally, we found that (i) the patterns of observed
precursors differed among the individual mutants and
(ii) the patterns of accumulating precursors were more
similar between hDIS3 D487N and R780K mutants than
those in cells expressing hDIS3G766R (Figure 5B).
Furthermore, despite the significant processing defects,
levels of mature 5.8S rRNA were not markedly reduced
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(Figure 5B). Consequently, neither ribosome biogenesis
nor polysome formation seemed to be significantly dis-
turbed (Supplementary Figure S9A). Interestingly, the
observed 5.8S rRNA precursors were incorporated into
polysomes (Supplementary Figure S9B). It is also worth
noting that their accumulation was not further increased
by siRNA-mediated silencing of hRRP6 expression
(Supplementary Figure S10).
Figure 4. Verification of DIS3 deletion and integration of hDIS3 expression cassette into the genome of DT40 Cre1 chicken cell line. (A) Schematic
representation of the fragment of DIS3 locus in DT40 Cre1 cells before (top) and after (bottom) integration of the hDIS3 expression cassette. Exons
are numbered. Positions of the left and right arm, used in recombination, and the 5-kb fragment deleted by cassette integration (removing the
majority of the chicken DIS3 RNB domain from the resulting protein), as well as elements of the integration cassette are indicated. NdeI and BsaI
sites used in Southern blot analysis are marked with arrows. Open arrowheads indicate LoxP sites, which were used for tamoxifen-induced Cre-
mediated excision of the hDIS3 expression cassette. Horizontal light-gray bar shows location of the probe used in Southern hybridization. Lengths of
the DNA fragments generated by restriction enzymes are indicated by italicized underlined numbers. Note that the size of the NdeI-derived fragment
differs in the case of the locus following integration, depending on the selection marker present (Puro or Bsr). (B) Results of Southern hybridization.
Total genomic DNA was isolated from the parental DT40 Cre1 cell line (lanes 2, 3, 6), heterozygotic DIS3 knockout with Puro selection marker
(lanes 4, 7) or homozygotic DIS3 knockout with both Puro and Bsr selection markers (lanes 5, 8). DNA was either nondigested (lane 2) or digested
with NdeI (lanes 3–5) or BsaI (lanes 6–8), transferred onto membrane and hybridized with a PCR-based probe as marked in (A). Sizes of the
molecular marker (GeneRulerTM 1kb Plus DNA Ladder from Fermentas; lane 1) are indicated on the left. Lengths of the restriction fragments
recognized by the probe (indicated on the right) are as expected.
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Figure 5. Model cell lines producing hDIS3 variants accumulate transcripts representing various RNA classes. (A) Low-resolution northern blot
analysis of steady-state levels of RNA molecules synthesized by different RNA polymerases. Total RNA was isolated from cell lines expressing either
WT or mutated hDIS3, either untreated (‘dox’) or treated with doxycycline (‘+dox’). Following electrophoretic separation in a denaturing agarose
gel, RNA was transferred onto a membrane, which was then sequentially hybridized with probes recognizing RNA pol I (5.8S rRNA precursor),
RNA pol II (histone H2A mRNA, GAPDH mRNA) or RNA pol III transcripts (RNase P RNA, RNase MRP RNA, 7SL RNA), and signals were
visualized by phosphorimaging. A significant increase in levels of 5.8S rRNA 30-extented precursors was visible on induction, while a more modest
accumulation was apparent for the histone H2A transcript, as well as RNase P and 7SL RNAs. For quantification of the results, see Supplementary
Figure S8A. (B) High-resolution northern blot analysis of 5.8S rRNA and its precursor. The same RNA samples as in (A) were resolved in
denaturing polyacrylamide gels for 1 h or for 2 h (‘longer run’; upper section). Following transfer, membranes were hybridized with probes for
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Figure 5. Continued
5.8S rRNA or the region downstream its 30 border (precursor probe); 5S rRNA was used as a loading control. Accumulation of slightly different
precursors was observable depending on the mutant hDIS3 variant, without concomitant decrease of mature 5.8S rRNA levels. (C) High-resolution
northern blot analysis of tRNAs. RNA samples as in (A) were separated in denaturing polyacrylamide gels and analyzed as above using probes for
various tRNAs. Induction-dependent accumulation was observed for the majority of analyzed tRNAs and precursors of tRNATyr and tRNACys,
particularly in cells producing hDIS3D487N and hDIS3R780K proteins. Hybridization with the probe for 5.8S rRNA served as positive control. For
quantification of the results, see Supplementary Figure S8B. (D) High-resolution northern blot analysis of selected sn/snoRNAs. RNA samples as in
(A) were analyzed as above, using probes specific to three different snRNA and U3 snoRNA. Induction-dependent accumulation was noticeable in
the case of U5 snRNA; hybridizations with probes for 7SL RNA and 5.8S rRNA served as positive controls. For quantification of the results, see
Supplementary Figure S8C. (E) Quantitative PCR analysis of different PROMPT regions and corresponding protein-coding transcripts in cell lines
bearing various hDIS3 mutations. The graph shows results of quantification of three independent experiments; values on the left represent fold
increase of transcripts in cells treated with doxycycline versus untreated cells. GAPDH mRNA, which was found to be relatively insensitive to hDIS3
mutations in northern blots [see panel (A)], was used for normalization. Abundance of all analyzed PROMPTs was significantly higher in cells
producing D487N and R780K hDIS3 variants compared with the WT control. This effect was not seen for mRNAs synthesized under the control of
respective promoters located downstream of three of the analyzed PROMPT regions or for the unrelated mitochondrial transcript, ATP6/8, which
was used as a negative control.
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Two recent publications underscored the importance of
exosome and catalytic Dis3 activities in particular, in the
global degradation of noncoding RNAs in yeast, and ac-
cumulation of tRNAs and their precursors was reported
as one of the most prominent phenotypes resulting from
Dis3 inactivation (37,53). These results, together with the
increased levels of other RNA polymerase III transcripts
in cells producing mutant hDIS3 (Figure 5A and
Supplementary Figure S8A), prompted us to analyze the
influence of hDIS3 mutations on selected tRNA molecules
more carefully. We noted that almost all examined mature
tRNA (except tRNATyr and tRNAPhe), as well as precur-
sors of tRNATyr and tRNACys, accumulate in cells bearing
exogenous hDIS3 with D487N or R780K mutations fol-
lowing doxycycline treatment (Figure 5C; for quantifica-
tion see Supplementary Figure S8B). Although the effect
was not as pronounced as for 5.8S rRNA precursors
(Figure 5A–D), it was reproducible. It is again worth
emphasizing that amino acid substitutions at positions
487 and 780 exerted stronger molecular phenotypes than
the G766R change (Figure 5C and Supplementary Figure
S8B).
We also investigated the impact of hDIS3 mutations on
the accumulation of U3 snoRNA and three different
snRNAs; however, we only noticed a phenotype for U5
snRNA that resembled the previously observed phenotype
with tRNAs (Figure 5D; for quantification see Supple-
mentary Figure S8C). We also analyzed PROMPTs,
which are unstable transcripts previously shown to accu-
mulate in cells subjected to siRNA-mediated depletion of
human exosome subunits (26,39,40). We found that the
levels of all analyzed PROMPTs were increased in all
cell lines producing mutated hDIS3 variants (Figure 5E).
In agreement with other analyses, accumulation of
PROMPTs was far more pronounced in cells bearing
hDIS3 D487N or R780K mutations than in the case of
G766R substitution (Figure 5E). Additionally, we
analyzed corresponding protein-coding transcripts
synthesized from promoters localized downstream of
three out of four PROMPTs and found that they were
not affected by hDIS3 mutations, similar to the unrelated
mitochondrially encoded transcript, ATP6/8 (Figure 5E).
In summary, hDIS3 mutations in our model cell lines
resulted in accumulation of the majority of analyzed
exosome substrates, including 5.8S processing intermedi-
ates, tRNAs, RNA polymerase III transcripts and
PROMPTs. Although the degree of accumulation was
variable among different exosome targets, in most cases
we observed more significant effects in cells producing the
hDIS3D487N and hDIS3R780K than the hDIS3G766R
variant.
MM-associated hDIS3 mutations lead to growth inhibition
of human cells and are synthetically lethal with PIN
domain catalytic mutations
We noticed that cells expressing hDIS3 variants with
D487N or R780K substitutions proliferated at somewhat
slower rate following the doxycycline-mediated induction
compared with the two other cell lines. Therefore, we per-
formed additional growth and metabolic analyses by
observing the untreated cells and their counterparts over
a long induction period, 48 h of culture, followed by
passage of cells into fresh medium containing doxycycline
and another 48 h of culture. While all cell lines grew
normally and comparably in medium lacking doxycycline,
on longer sh-miRNA–mediated repression of endogenous
hDIS3 and simultaneous expression of sh-miRNA-insensi-
tive exogenous hDIS3 variants, the four cell lines behaved
differently (Figure 6). hDIS3WT produced from the
integrated construct complemented the silenced endogen-
ous hDIS3, and the cell growth and metabolism were un-
disturbed (Figure 6A and B). In contrast, cells expressing
hDIS3D487N and hDIS3R780K variants exhibited inhibition
of growth and reduction of metabolic activity (Figure 6A
and B), while G766R mutation in hDIS3 exerted only
moderate effects (Figure 6A and B). These results
were in line with biochemical and functional data
(see Figures 1C, 2 and 5).
Next, we were interested in checking whether, as in
yeast, there is a synergistic effect of MM-associated
RNB domain mutations and dysfunction of hDIS3 PIN
domain endonuclease activity. We constructed analogous
stable cell lines bearing an additional mutation in the cata-
lytic site of PIN domain, D146N, which was previously
shown to abolish hDIS3 endonucleolytic activity in the
in vitro assays (26). Cell growth assays performed as
above revealed that the growth of cell lines expressing
hDIS3 variants with the D146N mutation was unaffected
in the absence of doxycycline (Figure 7A). On the other
hand, on induction, only cells expressing the hDIS3D146N
single mutant grew relatively normally and comparably
with its counterpart producing hDIS3WT, indicating that
endonuclease activity alone has little impact on cell physi-
ology (Figure 7A). In contrast, combination of the PIN
domain catalytic mutation with any mutation in the RNB
domain (D487N, G766R or R780K) strongly suppressed
survival of cells (Figure 7A). A synergistic effect of inacti-
vation of both nucleolytic activities of hDIS3 was most
pronounced in cells expressing the hDIS3D146N G766R
double mutant, particularly when noting that the cell
line producing the hDIS3G766R mutant alone displayed
mild growth inhibition compared with the WT control
(Figure 7A). Importantly, the metabolic activity of the
cells bearing mutations in the RNB domain was also add-
itionally reduced on accompanying inactivation of PIN
domain endonuclease (Figure 7B).
We then analyzed molecular phenotypes resulting from
combination of MM-associated hDIS3 mutations in the
RNB domain with disruption of PIN domain endonu-
cleolytic activity by comparing them with the respective
single mutants. As shown in Figure 7C, inactivation of the
PIN domain catalytic activity alone did not lead to accu-
mulation of 5.8S rRNA precursors. Interestingly, we were
not able to observe any synergistic effect of D146N sub-
stitution in the background of RNB domain mutations, as
the levels of precursor molecules were not further elevated
in cells expressing hDIS3D146N D487N, hDIS3D146N G766R
and hDIS3D146N R780K compared with the cells producing
respective hDIS3 versions with an intact PIN domain
(Figure 7C). This indicates that such 30-extended 5.8S
rRNA species are normally degraded mainly by hDIS3
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exoribonucleolytic activity. On the contrary, our results
clearly demonstrated that while the levels of different
PROMPTs were comparable between cell lines producing
either hDIS3 with D146N substitution or its WT
counterpart, the cells expressing hDIS3D146N D487N,
hDIS3D146N G766R and hDIS3D146N R780K double mutants
accumulated much higher amounts of PROMPTs than
the respective single mutants (Figure 7D), suggesting
the cooperative action of both nucleolytic activities
of hDIS3. Intriguingly, we noticed a highly similar
trend for protein-coding transcripts corresponding to
three out of four tested PROMPTs (but not for
mitochondrially encoded ATP6/8 mRNA, which we
would not expect to be affected by exosome dysfunction),
although the fold differences between double and single
mutants were not so prominent as in the case of
PROMPTs (Figure 7E).
In conclusion, although the molecular events linking
the inactivation of hDIS3 nucleolytic properties and its
inability to efficiently degrade transcripts with reduced
cell viability remain to be elucidated, the negative syn-
thetic interaction between MM-associated RNB domain
mutations and PIN domain dysfunction may suggest the
latter as a promising drug target for cancers bearing mu-
tations that affect hDIS3 RNB domain exonucleolytic
activity.
DISCUSSION
In this study, we showed that MM-associated hDIS3 mu-
tations have negative effects on hDIS3 protein function,
cell physiology and RNA metabolism, leading to
vulnerabilities that can be used for anti-cancer drug devel-
opment. Moreover, our analyses prove that DIS3 has an
essential function in RNA metabolism in vertebrates.
Inhibition of hDIS3 exonucleolytic activity by MM-
associated mutations
Results of biochemical assays indicate that in the majority
of cases, amino acids substituted in hDIS3 in MM patients
play an important role in regulating hDIS3 exoribonu-
cleolytic activity, which is generally in agreement with
data from literature and structural information. Five out
of six analyzed mutations are positioned in the RNB
domain, strictly associated with exoribonucleolytic
activity (Figure 1A; Supplementary Figure S11). The
only exception is isoleucine at position 845 (I845), which
is located in a less conserved region downstream of the
RNB domain; its occurrence is limited exclusively to the
human protein (Figure 1A; Supplementary Figure S11).
Accordingly, activity of hDIS3I845V was unaffected, irre-
spective of whether tested on single- or partially double-
stranded RNA substrates.
Figure 6. MM-associated hDIS3 mutations adversely affect cell growth and metabolic activity in a human cellular model. (A) Cell-growth analysis.
Equal amounts of cells from each line were seeded in culture dishes, subjected to doxycycline-mediated induction (48 h+48h) and analyzed by
microscopy. The cells harboring mutated hDIS3 grew worse than the cell line with WT protein. The strength of the growth phenotype was as follows:
hDIS3D487N> hDIS3R780K> hDIS3G766R. (B) Metabolic activity assay. Approximately equal numbers of cells from each stable cell line were grown in
triplicate in 96-well plates, either untreated (‘dox’) or treated with doxycycline (‘+dox’). AlamarBlue reagent was added to the cells after the
indicated time, and changes of metabolic status were evaluated by fluorescence measurements. In agreement with results from (A), hDIS3D487N and
hDIS3G766R mutants gave the strongest and weakest phenotype, respectively.
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Figure 7. Catalytic mutation in the hDIS3 PIN domain, responsible for endonucleolytic activity, leads to synergistic effects with MM-associated
mutations in the RNB domain. (A) Cell-growth analysis. Equal amounts of cells from each line were seeded in culture dishes, grown in the absence
(‘dox’) or presence (‘+dox’) of doxycycline and analyzed by microscopy. The cell lines producing hDIS3 with mutations in both catalytic domains
grew significantly worse than cells producing hDIS3 with mutations only in the RNB domain. Nontransfected HEK293 Flp-In T-Rex cells were
analyzed in parallel as a control. (B) Metabolic activity assay. Approximately equal numbers of cells from each stable cell line, or nontransfected
HEK293 Flp-In T-Rex cells, were grown in triplicate in 96-well plates, either untreated (‘dox’) or treated with doxycycline (‘+dox’). AlamarBlue
reagent was added after 72 h, and metabolic status was assessed by fluorescence measurements. In agreement with results from (A), cells producing
hDIS3 double mutants displayed lower metabolic activity than cells expressing protein variants with an intact PIN domain. (C) Catalytic mutation of
PIN domain does not enhance accumulation of 30-extended 5.8S rRNA precursor molecules. High-resolution northern blot analysis of 5.8S rRNA
and its precursor. Total RNA was isolated from cell lines producing WT hDIS3 or hDIS3 PIN or/and RNB domain mutants, which were all
subjected to doxycycline treatment. RNA samples were resolved in denaturing polyacrylamide gel for 2 h; following RNA transfer, nylon membranes
were hybridized with probes for mature 5.8S rRNA or to the region located downstream its 30 border (precursor probe); 5S rRNA was used as a
loading control. (D and E) Quantitative PCR analysis of different PROMPT regions (D) and corresponding protein-coding transcripts (E) in cell
lines producing hDIS3 variants. The graphs show results of quantification of three independent experiments; values on the left represent fold increase
of transcripts in cells expressing mutated versus WT hDIS3. GAPDH mRNA was used for normalization. Abundance of all analyzed PROMPTs was
highly increased in cells producing hDIS3 double mutants compared with cells expressing proteins harboring mutations only in the RNB domain (D);
the same trend was also observed for mRNAs synthesized under the control of respective promoters located downstream of three of the analyzed
PROMPT regions, but not for the unrelated mitochondrial transcript, ATP6/8, which was used as a negative control (E).
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Although our results do not allow us to directly propose
the possible mechanism of inhibition of hDIS3 exoribonu-
cleolytic activity resulting from MM-associated muta-
tions, some clues can be obtained following comparison
of the solved 3D structures of E. coli RNase II and yeast
Dis3 RNB domains {the latter in the context of exosome
core, according to the recently published structure of 11-
subunit exosome [(25); Supplementary Figure S12A]}. For
instance, S541 in S. cerevisiae Dis3 (an equivalent of S477
in hDIS3) and threonine in the corresponding position of
E. coli RNase II (Supplementary Figure S11) are located
in the proximity of RNB domain catalytic center
(Supplementary Figure S12B). We may hypothesize that
substitution with large amino acid, like arginine (as in the
case of the S477R hDIS3 mutation), may affect corres-
ponding b-sheet formation and most likely result in a
steric conflict and/or abolish hydrogen bonds required
for correct structure, therefore interfering with magnesium
coordination and decreasing enzymatic activity. On the
other hand, perfectly conserved G833 in yeast Dis3 (a
counterpart of G766 in hDIS3) is situated in the ‘neck
region’ conserved between RNase II and Dis3, which is
responsible for binding of the 30-end of RNA
(Supplementary Figure S12C). A potentially important
function of glycine in this particular position is further
underscored by the fact that the G833D mutation is
known to suppress degradation of hypomodified
tRNAMeti in S. cerevisiae (43,54). Introduction of a nega-
tively charged amino acid might disrupt the interaction
between protein and RNA. Substitution of glycine with
a bigger amino acid, such as arginine (as in the case of
the human G766R mutation), although positively
charged, may result in a steric hindrance. Additionally,
this particular glycine is located at the top of a loop,
and flexibility of this small amino acid may be crucial
for the structural integrity. In turn, R780/R847 in
Figure 7. Continued
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human/yeast Dis3 is in the same position as R500 in E.coli
RNase II; this amino acid is localized in the active site of
the bacterial enzyme [(55); Supplementary Figure S12D]
and its substitution with alanine leads to an over 40 000-
fold reduction of the exoribonucleolytic activity (56). We
may thus infer that, similar to E. coli RNase II, the role of
arginine in this specific location is to increase susceptibility
of the phosphodiester bonds present in RNA substrates to
cleavage. All the findings mentioned above nicely corrob-
orate our results demonstrating that the exoribonu-
cleolytic activity of hDIS3 is affected most significantly
in protein variants bearing S477R, G766R or R780K
mutation.
Contrary to the mutations mentioned above, V504G
substitution did not have any impact on hDIS3
exoribonucleolytic activity. It might be a bit surprising,
as valine in this position is perfectly conserved (Supple-
mentary Figure S11). However, superimposition of yeast
Dis3 and E. coli RNB domain structures reveals that its
counterpart in S. cerevisiae Dis3 (V568) is located at the
periphery of the protein (Supplementary Figure S12E).
Similarly, A588 in yeast Dis3 (equivalent of A524 in
hDIS3) is located far from the catalytic center, in a large
4-stranded b-sheet, inside a globular hydrophobic struc-
ture (Supplementary Figure S12F). Furthermore, it is the
least conserved amino acid, absent from E. coli RNase
II/R, which both contain a basic amino acid residue in
this position (K or R) (Supplementary Figure S11).
Although we were not able to assess the activity of the
hDIS3A524P protein variant due to its insolubility,
analyses performed in a yeast model indirectly indicate
that the dysfunction of such mutant is not so severe as
in the case of hDIS3G766R or hDIS3R780K versions.
Together these results show that some MM-associated
hDIS3 mutations exert strong effects on the ability of the
enzyme to exonucleolytically digest RNA substrates,
which is in agreement with the currently available struc-
tural information. However, it is important to point out
that other hDIS3 mutations, like I845V and V504G, do
not affect the enzyme activity, what may suggest that they
represent random mutational noise, since global
sequencing of tumor samples leads to the discovery of
thousands of single nucleotide polymorphisms and not
all of them are relevant to cancer development. Neverthe-
less, this does not diminish the significance of other
detected amino acid substitutions, as there are currently
60 described DIS3 mutations in the COSMIC database
(http://cancer.sanger.ac.uk/cancergenome/projects/cosmic)
and a large fraction of them is located in the conserved
region of the RNB domain.
Importance of hDIS3 and intactness of its RNB domain
for cell physiology
Results of multiple analyses performed in this study using
different models highlight the importance of hDIS3 and
intactness of its RNB domain for cell physiology. First,
knockout of both alleles of DIS3 gene in the chicken
DT40 cell line was found to be lethal, which demonstrated
for the first time that in vertebrates the gene is indispens-
able for survival, thus confirming findings in S. cerevisiae.
We used this model to analyze the influence of MM-
associated DIS3 mutations in the RNB domain on cell
viability and discovered that, in general, amino acid
changes leading to more significantly decreased enzymatic
activity of hDIS3 protein in vitro were reflected by more
severe molecular phenotypes and growth defects of corres-
ponding yeast mutant strains. This observation was in
turn corroborated by the results of assays performed
using our experimental system based on HEK293-
derived human cell lines.
Among the strongest molecular phenotypes caused by
MM mutations are increased levels of extended 5.8S pre-
cursor molecules, improperly processed at the 30-end, and
an intermediate in rRNA maturation pathway, 50-ETS. In
both yeast and human cells, accumulation was particularly
apparent in the case of mutations most adversely affecting
the activity of the protein. Intriguingly, in neither of the
two models was accumulation of 5.8S rRNA precursor
accompanied by concomitant significant decrease in the
levels of mature 5.8S rRNA. Furthermore, we found
that such precursors were successfully incorporated into
polysomes in human cells, indicating that their overa-
bundance may not influence protein synthesis.
Therefore, the significance of accumulation of these
species for cell physiology remains to be elucidated.
Moreover, not only full-length 5.8S precursors and
50-ETS but also their degradation intermediates
accumulated in the yeast mutants, confirming previous
observations that hDIS3 exoribonucleolytic activity
plays a crucial role in their removal from the cell (18). It
also appears that RRP6 exonuclease cannot fully take
over hDIS3 functions in the degradation of such RNA
species in the nucleus, as neither the deletion of RRP6
gene in yeast nor RNA interference (RNAi)-based sup-
pression of hRRP6 expression is human cells had an
additive effect on their accumulation. However, our
results do not provide explanation as to whether aberra-
tions in ribosomal RNA maturation pathway are directly
associated with cell growth defects.
Further analyses of molecular phenotypes resulting
from MM-associated hDIS3 mutations in human cells
revealed that inhibition of hDIS3 exoribonucleolytic
activity results in decreased degradation rate of RNA mol-
ecules belonging to other RNA classes, such as tRNAs
and their precursors, snRNAs and other small RNAs,
including RNase P RNA and 7SL RNA. One of the
most interesting and reproducible phenotypes was the
strong accumulation of PROMPTs, unstable transcripts
synthesized by RNA Pol II upstream many promoters of
protein-coding genes. Moreover, accumulation of
PROMPTs was further enhanced when MM-associated
RNB domain mutations were combined with hDIS3
D146N (endo) mutation within PIN domain, indicating
that degradation of these RNA species requires both
exonucleolytic and endonucleolytic activities of hDIS3.
It should be also pointed out that DIS3 mutations in
yeast (in which Dis3p is present both in the nucleus and
the cytoplasm) lead to the accumulation of nuclear
noncoding RNAs somewhat related to human
PROMPTs, namely CUTs. This indicates that the level
of ‘transcriptional noise’ is probably much higher in the
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nucleus of the cells producing mutated hDIS3 variants.
Whether and how this may affect physiology, metabolic
activity and survival potential of the cells remains to be
addressed. Furthermore, it is essential to apply high-
throughput sequencing analyses to obtain deeper insights
into the transcriptome changes resulting from MM-
associated hDIS3 mutations.
Moreover, the role of hDIS3 mutations in cancer devel-
opment remains to be determined. One possibility is the
involvement of hDIS3 as a part of the exosome complex,
known to be involved in AID-mediated immunoglobulin
hypermutations and class switches (48), which lead to
DNA translocations associated with MM development.
The mutations may also have specific direct effects on
gene expression; alternatively, as the exosome is the
main enzyme degrading unstable transcripts from
noncoding regions and some such transcripts affect chro-
matin structure, their overabundance resulting from
hDIS3 dysfunction may indirectly affect expression of
genes important for carcinogenesis. All of that remains
to be experimentally verified using true MM models, but
since thus far there is no single established MM cell line
with hDIS3 mutation affecting activity of the protein, this
is a challenging task.
hDIS3 PIN domain as a potential drug target for cancers
bearing mutations in hDIS3 RNB domain
Synthetic lethality has recently emerged as one of the most
promising strategies for development of targeted cancer
therapies (57). Such a strategy enables the targeting of
cancer cells with a potentially low effect on untransformed
cells. For example, breast cancer cells with mutations in
the BRCA1 and BRCA2 are sensitive to inhibition of poly
[ADP-ribose] polymerase (PARP1), whereas inhibition of
PARP1 has little influence on survival and proliferation of
normal cells with WT BRCA (58,59). Lead compounds
based on PARP1 inhibitors are in advanced clinical
trials (60).
In the yeast system, both deletion of accessory nuclear
exosome catalytic subunit Rrp6 and inactivation of Dis3
PIN endonuclease domain are synthetically lethal with
mutations abolishing Dis3 exonucleolytic activity. Since
we show here that, as in yeast, vertebrate DIS3 is essential
for cell survival, it was possible that similar synthetic inter-
actions could exist in the case of hDIS3. Results presented
herein indicate that MM-associated mutations in hDIS3
RNB domain, inhibiting its exonuclease activity, are
indeed synthetically lethal with inactivation of hDIS3
endonucleolytic activity. This is valid for both the yeast
and cellular model described in this publication. In human
cells, the combination of MM mutations with mutations
in the PIN domain had a cumulative effect on cell growth
inhibition and accumulation of exosome targets.
In contrast to inactivation of the DIS3 PIN domain,
deletion or depletion of RRP6 was not synthetically
lethal with MM-associated hDIS3 mutations.
In summary, our data suggest the hDIS3 PIN domain
but not hRRP6 as a drug target for cancers bearing hDIS3
mutations. Importantly, mutations inactivating the hDIS3
PIN domain alone have little effect on cell physiology,
since research performed by us and others did not reveal
any detectable phenotype of hDIS3 PIN domain dysfunc-
tion without the presence of other mutations. This
suggests that the active site of the hDIS3 PIN domain
endonuclease may be a particularly promising drug
target for cancers bearing mutations affecting hDIS3
RNB domain exonucleolytic activity. This is especially im-
portant for MM, as it remains incurable, although we
cannot exclude the possibility that due to differences in
physiology, synthetic interactions between mutations in
hDIS3 PIN and RNB domains might not occur in MM
cells. The DIS3 PIN domain structure is solved and the
in vitro assays for its endoribonucleolytic activity have
been developed, what is an additional advantage that
should facilitate identification of its inhibitors based on
classical medical chemistry or virtual screening for
putative lead compounds.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [61–65].
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